HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rita Raddatz Selected Research

6- (4- (3- (2- methylpyrrolidin- 1- yl)propoxy)phenyl)- 2H- pyridazin- 3- one

1/2012CEP-26401 (irdabisant), a potent and selective histamine H₃ receptor antagonist/inverse agonist with cognition-enhancing and wake-promoting activities.
7/2011Discovery and characterization of 6-{4-[3-(R)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (CEP-26401, irdabisant): a potent, selective histamine H3 receptor inverse agonist.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rita Raddatz Research Topics

Disease

1Sleep Wake Disorders
01/2016
1Schizophrenia (Dementia Praecox)
01/2012
1Cognitive Dysfunction
07/2011
1Central Nervous System Diseases (CNS Diseases)
01/2010

Drug/Important Bio-Agent (IBA)

26- (4- (3- (2- methylpyrrolidin- 1- yl)propoxy)phenyl)- 2H- pyridazin- 3- oneIBA
01/2012 - 07/2011
13- (1'- cyclobutylspiro(4H- 1,3- benzodioxine- 2,4'- piperidine)- 6- yl)- 5,5- dimethyl- 1,4- dihydropyridazin- 6- oneIBA
01/2016
1Antipsychotic Agents (Antipsychotics)IBA
01/2012
1Histamine (Histamine Dihydrochloride)FDA Link
07/2011
1Histamine H3 AntagonistsIBA
01/2010

Therapy/Procedure

1Therapeutics
01/2012